Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.31%
0%
-23.31%
6 Months
-69.83%
0%
-69.83%
1 Year
-70.54%
0%
-70.54%
2 Years
-96.46%
0%
-96.46%
3 Years
-99.32%
0%
-99.32%
4 Years
-99.89%
0%
-99.89%
5 Years
-99.83%
0%
-99.83%
AegirBio AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
0.41%
EBIT to Interest (avg)
-14.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.14
Sales to Capital Employed (avg)
0.01
Tax Ratio
2.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.40
EV to EBIT
-1.08
EV to EBITDA
-1.08
EV to Capital Employed
11.08
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1029.83%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.10
-100.00%
Operating Profit (PBDIT) excl Other Income
-22.30
-44.00
49.32%
Interest
10.20
10.00
2.00%
Exceptional Items
-13.30
0.00
Consolidate Net Profit
-49.60
-59.70
16.92%
Operating Profit Margin (Excl OI)
0.00%
-657,782.60%
65,778.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -100.00% vs -94.12% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 16.92% vs 83.54% in Dec 2023
About AegirBio AB 
AegirBio AB
Pharmaceuticals & Biotechnology
Aegirbio AB is a Sweden-based diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's tests for optimized dosage of biological drugs focused on diseases in neurology, autoimmune diseases and cancer.
Company Coordinates 
Company Details
C/o IDEON SCIENCE PARK, Solvegatan 43 , LUND None : 223 70
Registrar Details






